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Abstract
Background: Immature bone marrow B cells are known to have longer CDR3 than mature
peripheral B cells, and this genetic characteristic has been shown to correlate with autoreactivity
in these early cells. B-cell Central tolerance eliminates these cells, but it is known that autoreactive
B cells nevertheless appear commonly in healthy human blood. We examined over 7,300 Ig genes
from Genbank, including those annotated by their discoverers as associated with autoreactivity, to
determine the genetic correlates of autoreactivity in mature B cells.
Results: We find differential biases in gene segment usage and higher mutation frequency in
autoreactivity-associated Ig genes, but the CDR3 lengths do not differ between autoreactive and
non-autoreactive Ig genes. The most striking genetic signature of autoreactivity is an increase in the
proportion of N-nucleotides relative to germline-encoded nucleotides in CDR3 from autoreactive
genes.
Conclusion:  We hypothesize that peripheral autoreactivity results primarily from somatic
mutation, and that the genetic correlates of autoreactivity in mature B-cells are not the same as
those for autoreactivity in immature B cells. What is seen in mature autoreactive B cells are the
correlates of autoreactive potential, not of autoreactivity per se. The autoreactive potential is higher
for V(D)J rearrangements encoded to a large extent by N-nucleotides rather than by the gene
segments that, we posit, have been selected in germline evolution for their suppression of
autoreactive potential.
Background
Self-reactive immunoglobulins (Ig) are generated at high
frequency during normal B-cell ontogeny in the bone mar-
row. Functional Ig genes result from the combinatorial
joining of gene segments from two (light chain) or three
(heavy chain) classes; V (variable), D (diversity), and J
(joining) [1,2]. This process, known as V(D)J recombina-
tion, generates tremendous receptor diversity through the
pairing of various gene segments, the selection of the
recombination sites at which the segments are joined, and
the addition of non-templated nucleotides (n-nucleotides)
between adjoining gene segments. These processes are sto-
chastic and can produce 1014 or so different protein specif-
icities to be generated from the fewer than 100 gene
segments at the immunoglobulin heavy chain locus [3]. In
response to antigenic stimuli, mature B-cells undergo fur-
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ther diversification through somatic hypermutation
(SHM), whereby mutations are introduced into the rear-
ranged immunoglobulin gene at a rate approximately 106
times higher than the normal background rate [4]. The
adaptive immune system generates diversity and adapts its
antigen receptors via stochastic somatic processes as
microbes themselves diversify and adapt through Darwin-
ian evolution. With such randomness in the formation of
antigen receptor genes, it is inevitable that autoreactivity
will arise. Indeed, 55–75% of early bone-marrow B-cells
express polyreactive and self-reactive surface Ig [5]. Three
primary B-cell-specific mechanisms for avoiding Ig-medi-
ated autoimmunity have been identified: selective deletion,
anergy and receptor editing [6-10].
Experiments using site-directed mutagenesis and CDR3
replacement have shown that the heavy chain CDR3 pro-
vides the primary structural correlates of polyreactivity
[11,12]. Shiokawa et al [13] found that CDR3 length dif-
fers between neonates and adults and provided evidence
for somatic selection on CDR3 length during B-cell devel-
opment. Aguilera et al [14] examined 8 autoreactive mon-
oclonal antibodies, and found no clear relationship
between polyreactivity and heavy chain CDR3 length.
Wardemann et al [5] pooled immature and bone marrow
"new emigrant" B-cells to show that cells reactive to HEp-
2 cell exctract are biased toward longer CDR3 compared to
those that are not so reactive.
Autoantibodies are commonly present in healthy human
serum [15]; in murine models, positive selection for some
autoreactive antibodies has been observed [16]. It is pos-
sible that these autoantibodies result largely from "leaki-
ness" of negative selection in the bone marrow, in which
case one expects autoantibodies in the periphery to bear
the same genetic signatures as autoantibodies in imma-
ture B cells. But they may also arise in the periphery via
somatic mutation after central tolerance has acted. In this
case, we might expect to find a genetic signature of auto-
reactivity, which may differ from that common to pre-
selection autoreactive cells in the bone marrow.
To determine the genetic signature of peripheral autoreac-
tivity, we performed a comprehensive and comparative
study of over 7,300 Ig collected from Genbank. We assem-
bled four sets of human heavy chain genes for compari-
son: a set of productive Ig genes for which evidence of
autoreactivity does not exist (P); a heterogeneous set of
genes annotated by their discoverers as associated with
autoreactivity, but exlcuding rheumatoid arthritis (A); a
set genes annotated as associated with rheumatoid arthri-
tis (RA); and a set of genes (NP) that appear to have been
rearranged out-of-frame and thus nonproductively.
We performed a detailed analysis of each gene set in terms
of gene segment composition, CDR3 length, n-nucleotide
addition, and mutation frequency, and employed statisti-
cal methods to detect biases that may exist among these
sets. We find differential biases in gene segment usage and
n-nucleotide tract length, but not in CDR3 length between
autoreactive and non-autoreactive productive genes. We
do, however, find a striking increase in the proportion of
n-nucleotides in CDR3 from autoreactive genes. This fact
suggests to us that germline gene segments have evolved
under selective pressure, not only to avoid autoreactivity,
but to avoid acquiring autoroactivity through somatic
mutation. Consequently, autoreactivity in the periphery
arises more frequently by somatic mutation in those genes
in which the CDR3s are encoded more extensively by n-
nucleotides rather than germline gene segments.
Results
Gene Segment Usage
For the J segments, both the A and NP gene sets showed
significant differences compared to every other gene set, as
did the RA and P gene sets, except when compared to each
other (Figures 1, 2). All possible pairs among the four
gene sets showed statistically significant J-gene segment
usage differences except for the RA vs P gene comparison.
The V and D segments outnumber J segments by factors of
eight and four, respectively, and are divided into seven
families each based on sequence homology. Looking at
the frequency of V segment usage by family, we observe
statistically significant differences among all gene sets
(Figures 1, 2). For both the A and RA genes, the most nota-
ble observation is the increase of 50% and 130%, respec-
tively, of segments from family VH1 relative to normals,
but a 26% and 67% decrease, respectively, in the relative
use of segments from family VH4 (Figure 2). The RA genes
also showed dramatic enhancements in the usage of seg-
ments from family VH2 and VH5 by four- and two-fold,
respectively, relative to the P genes (Figure 2). For the NP
genes, we observed the opposite trend in family VH4, with
67%, 115%, and 34% relative increases of segment usage
relative to the P, A, and RA genes, respectively.
Among the productive gene sets, we did not observe statis-
tically significant differences in D segment usage by family
(Figures 1, 2). The NP genes, however, did differ signifi-
cantly from each of the three productive gene sets. We also
observed significant enhancements of 33% and 136% in
the number of apparent inverted D-segments used in the
A and RA genes, respectively, relative to the P genes (p =
0.02).
Somatic Mutations
We observed significantly higher mutation frequencies of
4.7% and 4.9% for the A and RA genes, respectively, com-
pared to the P genes (p < 10-10). These values represent a
46% and 47% relative increase over the observed muta-
tion frequency for the P genes of 3.2%. Despite higherImmunome Research 2009, 5:1 http://www.immunome-research.com/content/5/1/1
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mutation frequencies, we did not observe a significant dif-
ference in the ratio of non-synonymous to synonymous
mutations in the three gene sets (Figure 3). Mutation fre-
quencies were calculated from observed mutations within
the V segment only of each Ig gene.
CDR3 length
We observed mean CDR3 lengths of 15.49 aa, 15.58 aa,
and 15.35 aa for the P, A, and RA genes, respectively (Fig-
ure 4). The differences among these means are not statis-
tically significant. We did, however, observe a statistically
significantly increased CDR3 length in the NP genes com-
pared to each of the productive gene sets. Plotting the
cumulative distribution functions for the CDR3 data for
each gene set shows that the CDR3 lengths of the P, A, and
RA genes are distributed similarly, while the distribution
of lengths for NP gene CDR3 lengths differs (Figure 5).
N-nucleotide Frequency
We observed significant differences for the mean N-nucle-
otide tract lengths in both the V-D and D-J junctions
among the four gene sets (Figure 4). In particular, the A,
RA, and NP sequences differed significantly from the P
sequences, with relative increases of 14%, 9%, and 24%,
respectively, in the V-D junction and relative increases of
26%, 21%, and 17%, respectively, in the D-J junction. In
neither junction did we observe differences among the A,
RA, and NP sequences sets.
We further computed the ratio of N-nucleotides to germ-
line-encoded nucleotides in each of the three productive
gene sets. Figure 4 shows the mean ratios and indicates
that there is a statistically significant difference in these
mean ratios between the A and RA genes relative to the P
genes, but that no such difference exists between the A and
RA genes.
Discussion
In spite of selection against B cells bearing autoreactive
antigen receptors during ontogeny in the bone marrow,
substantial frequencies of autoreactive B cells in the
periphery are observed. There are two hypotheses, not
mutually exclusive, to account for this fact. One such
hypothesis holds that such selection is intrinsically leaky,
and that autoreactivity in the periphery is due largely to
original autoreactivity that has slipped through the selec-
tive filter. The other hypothesis does not depend on leak-
iness of central B cell tolerance, but instead relies on the
generation of autoreactivity by somatic mutations incor-
porated after primary B cell development.
These two hypotheses make different predictions regard-
ing the relationships one will find between the genetic sig-
natures of autoreactive Ig in the bone marrow and those
in the periphery. If peripheral autoreactivity is due prima-
rily to the escape of original autoreactivity from central
tolerance, we expect to find that autoreactive peripheral B
cells will be similar to pre-selection and autoreactive B
cells in the bone marrow. The main distinguishing feature
of such cells is a long CDR3. We find no statistically sig-
nificant difference between CDR3 lengths in autoreactive
and non-autoreactive Ig, though CDR3 is much longer in
NP sequences than in any other class, confirming the
observation by others that selection during primary
ontogeny favors shorter CDR3.
No such correspondence is necessary under the second
hypothesis. What one does expect to see under the second
hypothesis are differences in somatic mutation, and we do
indeed find that the mutation frequency is about 50%
higher in autoreactivity-associated genes than in non-
autoreactive genes. This result is consistent with many
previous studies of the role of somatic mutation in
autoimmunity [17-22]. Beyond the simple observation of
Analysis of gene segment frequencies among the four data- sets Figure 1
Analysis of gene segment frequencies among the four 
datasets. P-values for chi-square analyses between all com-
binations of sequence sets. P-values lower than 0.05 are high-
lighted in gray.
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Gene segment usage frequencies Figure 2
Gene segment usage frequencies. Observed frequencies of gene segment usage in the P, A, RA, and NP gene sets. Error 
bars represent 95% confidence intervals.
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differential mutation frequencies, however, we do see
additional genetic biases that distinguish the autoreac-
tives from the normals.
We observe, for example, differential usage in both VH and
JH gene segments, with an increase in VH1 family usage in
genes from both the general autoimmune (A) and rheuma-
toid arthritis (RA) datasets, as well as a corresponding
reduction in family VH4 usage. Family VH4 is typically sec-
ond-highest in usage frequency and has been reported to
provide some of the most frequently used segments in the
adult Ig repertoire, particularly V4-34 [23-26].
If peripheral autoreactivity were due largely to the leaki-
ness of central tolerance, we would expect gene segment
usage in autoantibodies to trend toward the pre-selection
repertoire represented by the non-productively rearranged
genes. This is not what we find. In fact, the VH segment
use in the A and RA genes is not intermediate between the
NP and normal genes, it is less like that of the NP genes
than the normals are. VH1, for example, has a higher fre-
quency in the normal genes than in the NP genes, and
higher frequency still in the A and AR genes, while VH4 is
lower in normals than in NP and lower still in A and AR.
The selective enhancement of usage for VH1 and VH5 seg-
ments in the A and RA genes may be due partially to the
presence of charged residues in the framework region of
these gene segments. Studies of autoimmune anti-erythro-
cyte human protein antibodies and non-autoimmune
anti-staphylococcal antibodies show that framework
region 1 may play a critical role in effective binding to
these antigens [27,28]. The VH1 and VH5 family genes
contain a lysine-lysine amino acid motif in framework 1,
which would produce a positively charged region in the
folded protein. No other VH segment contains a contigu-
ous pair of positively charged residues. We did also
observe an enhancement of VH5 segment usage in the RA
genes. Thus, it may be possible that part of the framework
region 1 of the VH1 family genes promotes binding to
some self-antigens.
We did observe, however, significant differences in the
proportions of N-nucleotides among CDR3 nucleotides
between either autoreactive set and the normals. This
result is consistent with those from studies showing that
TdT-deficient mice crossed with autoimmune-prone mice,
which make B- and T-cells with nearly no N-nucleotides,
have lower incidence of autoimmune disease and longer
life spans than non-TdT deficient autoimmune-prone
controls [29,30].
These analyses suggest to us that the premutation genetic
signatures observed in the autoreactive sets are indicative
Analysis of somatic mutations and N-nucleotides among the functional datasets Figure 3
Analysis of somatic mutations and N-nucleotides among the functional datasets. P-values for chi-square analyses 
between the functional Ig datasets with respect to mutation frequency, mutation types, and ratio of N-nucleotides to germline-
encoded nucleotides.
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of autoreactive potential, and mark those genes that are
more likely to give rise to autoreactivity under somatic
mutation. B-cell central tolerance can only counter-select
V(D)J rearrangements that are already autoreactive, not
those with a tendency to become autoreactive. Germline
evolution, however, can and does select gene segments for
their potential repertoire under somatic mutation [31,32].
The idea is that germline VH, DH, and JH gene segments
have been shaped by evolution to avoid becoming autore-
active too easily under somatic hypermutation. When
much of CDR3 is encoded by N-nucleotides rather than
by these time-tested gene segments, autoreactivity may be
much closer in genotype space than it would otherwise be.
Conclusion
We have examined the genetic correlates of B cell autore-
activity by compiling a large set of Ig genes associated with
autoimmunity and comparing these genes statistically to
normal and non-productive Ig gene sequences. We do not
find a difference in CDR3 length between the autoimmu-
nity-associated genes and the normals, as one might
expect. There are, however, marked differences in muta-
tion frequency between these sets, differences in gene-seg-
ment usage frequency, and, most strikingly, an increased
use of N-nucleotides in the autoimmune genes. The
hypothesis that ties these results together is that the pre-
mutation genetic signature of peripheral B-cell autoreac-
tivity is not related to autoreactivity per se (because
autoreactivity is largely eliminated by counter-selection in
the bone marrow) but to autoreactive potential, the pro-
clivity to become autoreactive under somatic hypermuta-
tion.
Methods
DNA sequences
We compiled two sets of human immunoglobulin heavy
chain gene sequences intended to be representative of the
Analysis of CDR3 Figure 4
Analysis of CDR3. Mean numbers of N-nucleotides in the 
two junctions, and mean CDR3 length. p-values are based on 
chi-square analyses.
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the naturally-occurring adult human repertoires. We
excluded clonally-related genes and genes of perinatal ori-
gin. To do so, we submitted the search "human [orgn]
heavy [titl] immunoglobulin [titl]" to the Genbank nucle-
otide database which returned 16,870 results. We further
identified 1,167 autoreactive Ig rearrangements in Gen-
bank using keyword searches with terms such as "autore-
active", "immunoglobulin", "autoantibody", and
"heavy". We also identified a third set of 608 gene
sequences from a study conducted on the synovial B-cells
of rheumatoid arthritis (RA) patients [33]. We down-
loaded each set of DNA sequences, preprocessed and fil-
tered them as described below, and analyzed them for
gene segment usage, point mutations, n-nucleotide addi-
tion, and recombination junctional diversity. Note that
the last nucleotide (or more) consistent with the relevant
gene segment may be a "cryptic" N-nucleotide. We con-
sistently identify such nucleotide as germline-encoded in
spite of this uncertainty. The larger set would be desig-
nated as productive, non-autoreactive genes (P), while the
smaller set would be designated as productive, autoreac-
tive genes (A). The automated analysis was performed
using our in-house software SoDA [34].
Classification by Productivity
Each dataset was divided into two groups on the basis of
their inferred original, pre-somatic mutation productivity.
We classified those sequences that had no stop codons
and both invariant V cysteines and the invariant J tryp-
tophan in-frame and intact as productive. Those that
appeared to have been originally rearranged out of frame
by virtue of the VH segment being out of frame with the
JH segment, excluding indels, were classified as non-pro-
ductive (NP). All others were classified as indeterminate
and were omitted from further consideration.
Filtering
We then filtered the SoDA results in each of the four sets
to remove clonal duplicates, which we defined to be those
sequences that were inferred to use the same V, D, and J
gene segments, had the same inferred CDR3 length, and
have similar Genbank accession numbers. Sequences con-
taining these matches and differing only by point muta-
tions were still considered clonal duplicates. Where
groups of clonally related genes were identified, a single
representative was chosen at random and the others were
omitted. We then grouped the sequences in each set by
study of origin and removed any large sets of sequences
that came from the same study.
The P sequences were further filtered to remove those
sequences that, by their own Genbank annotations, indi-
cated origin from neonates or cordblood. The P sequences
were also filtered to remove any sequences that may be
autoreactive due to the inclusion of at least one of the fol-
lowing words in the Genbank record: "self-reactive",
"anti-self", "lupus", "rheumatoid", "sjogren", "diabetes",
"sclerosis", "wegener", "crohn", "addison", "sclero-
derma", "grave", "psoriasis", "celiac", "vasculitis", "coli-
tis", and "thyroiditis".
Each autoreactive sequence was then manually verified to
ensure that its Genbank record indicated autoreactivity.
The A dataset was also filtered to remove those genes that
were specifically anti-DNA, since these genes would bias
the CDR charge measurements. The final set of P genes
contained 6490 DNA sequences, the final set of A genes
contained 254 sequences, the final set of RA sequences
from the rheumatoid arthritis study contained 608
sequences, and the final set of NP sequences contained
325 genes.
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